135 related articles for article (PubMed ID: 8277507)
1. Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase.
Goudgaon NM; Naguib FN; el Kouni MH; Schinazi RF
J Med Chem; 1993 Dec; 36(26):4250-4. PubMed ID: 8277507
[TBL] [Abstract][Full Text] [Related]
2. Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.
Ashour OM; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
Biochem Pharmacol; 2000 Sep; 60(5):687-92. PubMed ID: 10927027
[TBL] [Abstract][Full Text] [Related]
3. Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase: relevance to chemotherapy.
Ashour OM; Al Safarjalani ON; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
Cancer Chemother Pharmacol; 2000; 45(5):351-61. PubMed ID: 10803917
[TBL] [Abstract][Full Text] [Related]
4. Circadian rhythm of orotate phosphoribosyltransferase, pyrimidine nucleoside phosphorylases and dihydrouracil dehydrogenase in mouse liver. Possible relevance to chemotherapy with 5-fluoropyrimidines.
Naguib FN; Soong SJ; el Kouni MH
Biochem Pharmacol; 1993 Feb; 45(3):667-73. PubMed ID: 8442766
[TBL] [Abstract][Full Text] [Related]
5. Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2',3',5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy.
Ashour OM; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
Cancer Chemother Pharmacol; 2000; 46(3):235-40. PubMed ID: 11021741
[TBL] [Abstract][Full Text] [Related]
6. New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers.
Naguib FN; el Kouni MH; Chu SH; Cha S
Biochem Pharmacol; 1987 Jul; 36(13):2195-201. PubMed ID: 3606636
[TBL] [Abstract][Full Text] [Related]
7. Development of inhibitors of pyrimidine metabolism.
Cha SM
Yonsei Med J; 1989 Dec; 30(4):315-26. PubMed ID: 2697111
[TBL] [Abstract][Full Text] [Related]
8. Activity of acyclic 6-(phenylselenenyl)pyrimidine nucleosides against human immunodeficiency viruses in primary lymphocytes.
Goudgaon NM; Schinazi RF
J Med Chem; 1991 Nov; 34(11):3305-9. PubMed ID: 1720175
[TBL] [Abstract][Full Text] [Related]
9. 5-Benzylbarbituric acid derivatives, potent and specific inhibitors of uridine phosphorylase.
Naguib FN; Levesque DL; Wang EC; Panzica RP; el Kouni MH
Biochem Pharmacol; 1993 Oct; 46(7):1273-83. PubMed ID: 8216379
[TBL] [Abstract][Full Text] [Related]
10. Acyclonucleoside analogues consisting of 5- and 5,6-substituted uracils and different acyclic chains: inhibitory properties vs purified E. coli uridine phosphorylase.
Drabikowska AK; Lissowska L; Draminski M; Zgit-Wroblewska A; Shugar D
Z Naturforsch C J Biosci; 1987 Mar; 42(3):288-96. PubMed ID: 2954322
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils.
Orr GF; Musso DL; Boswell GE; Kelley JL; Joyner SS; Davis ST; Baccanari DP
J Med Chem; 1995 Sep; 38(19):3850-6. PubMed ID: 7562916
[TBL] [Abstract][Full Text] [Related]
12. Uridine phosphorylase inhibitors: chemical modification of benzyloxybenzyl-barbituric acid and its effects on urdpase inhibition.
Guerin DJ; Mazeas D; Musale MS; Naguib FN; Al Safarjalani ON; el Kouni MH; Panzica RP
Bioorg Med Chem Lett; 1999 Jun; 9(11):1477-80. PubMed ID: 10386920
[TBL] [Abstract][Full Text] [Related]
13. 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase.
Niedzwicki JG; Chu SH; el Kouni MH; Rowe EC; Cha S
Biochem Pharmacol; 1982 May; 31(10):1857-61. PubMed ID: 7104017
[TBL] [Abstract][Full Text] [Related]
14. 5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase.
el Kouni MH; Goudgaon NM; Rafeeq M; Al Safarjalani ON; Schinazi RF; Naguib FN
Biochem Pharmacol; 2000 Sep; 60(6):851-6. PubMed ID: 10930540
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases.
Niedzwicki JG; el Kouni MH; Chu SH; Cha S
Biochem Pharmacol; 1983 Feb; 32(3):399-415. PubMed ID: 6847695
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of nucleobase ligands of uridine phosphorylase from Toxoplasma gondii.
Iltzsch MH; Klenk EE
Biochem Pharmacol; 1993 Nov; 46(10):1849-58. PubMed ID: 8250971
[TBL] [Abstract][Full Text] [Related]
17. 3-Cyano-2,6-dihydroxypyridine (CNDP), a new potent inhibitor of dihydrouracil dehydrogenase.
Tatsumi K; Yamauchi T; Kiyono K; Kishi K; Yanagihara Y; Imaoka T; Kawaguchi T; Kubo M
J Biochem; 1993 Dec; 114(6):912-8. PubMed ID: 8138551
[TBL] [Abstract][Full Text] [Related]
18. Resistance of human immunodeficiency virus type 1 to acyclic 6-phenylselenenyl- and 6-phenylthiopyrimidines.
Nguyen MH; Schinazi RF; Shi C; Goudgaon NM; McKenna PM; Mellors JW
Antimicrob Agents Chemother; 1994 Oct; 38(10):2409-14. PubMed ID: 7840579
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of uridine phosphorylase. Synthesis and structure-activity relationships of aryl-substituted 1-((2-hydroxyethoxy)methyl)-5-(3-phenoxybenzyl)uracil.
Orr GF; Musso DL; Kelley JL; Joyner SS; Davis ST; Baccanari DP
J Med Chem; 1997 Apr; 40(8):1179-85. PubMed ID: 9111291
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 1-[[2-hydroxy-1-(hydroxymethyl)ethoxy] methyl]-5-benzyluracil and its amino analogue, new potent uridine phosphorylase inhibitors with high water solubility.
Lin TS; Liu MC
J Med Chem; 1985 Jul; 28(7):971-3. PubMed ID: 4009620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
